Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cancer

Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data

Silexion Therapeutics Corp. (NASDAQ:SLXN) stock is trading higher on Thursday, with a session volume of 16.87 million compared to the average volume of 74.2 thousand as per data from Benzinga Pro.

Benzinga

Indigestion is commonplace but sometimes concerning. Here’s what you need to know

Every so often, a completely random advert stops me in my tracks and makes me wonder what on earth went on in the room where it was created. For me, that moment came this past weekend, courtesy of a bubblegum-pink, cheerfully surreal advert for Pepto-Bismol.

The Conversation

Mother to join Kiltwalk to raise funds for charity she set up in son’s memory

Six-year-old Jaxon McKenzie, from West Lothian, died last December just eight months after being diagnosed with a brain stem tumour.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

GMC examines doctor’s Reform speech linking vaccines to royal family cancer

Medical bodies and prime minister condemn Aseem Malhotra’s ‘pseudo-science’ remarks at party conference

The Guardian - UK

What the latest NHS hospital figures for England show

The waiting list for routine hospital treatment has risen for the second month in a row.

Evening Standard

Concern over late-stage diagnosis of cancer

A number of audits into cancer care in England and Wales have been published by experts.

Evening Standard

Waiting list for planned hospital treatment rises for second month in a row

The Government has said it has an ‘ambitious target’ to cut maximum wait times from 18 months to 18 weeks for NHS patients across England.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Longevity isn’t a lifestyle — it’s about using precision medicine to fight the inevitable diseases that kill

Steve Brown’s outlines why he’s weary of the longevity industry – and how it can improve

Evening Standard

Prince Harry Reconnects with King Charles over Cancer Battle—'He's Great,' Says Duke

Prince Harry reunited with King Charles in London as the monarch continues cancer treatment, describing his father as 'great' in a rare personal update.

International Business Times UK

Cancer patients in England now face longer diagnosis waits than four years ago, report says

IN FULL

The Independent UK

Only half of people with cancer are diagnosed within NHS target time, analysis finds

Urgently referred patients are having to wait more than 28 days to receive a cancer diagnosis, exceeding NHS England’s target time

The Independent UK

Only half of people with cancer diagnosed within target time, analysis finds

Cancer Research UK said its study shows that for people being diagnosed with cancer, things have been getting worse instead of better.

The Independent UK

Man Diagnosed With Testicular Cancer Left Stunned When Blood Tests Said He Was Pregnant

“My blood results were showing up as positive on a pregnancy test like I was two weeks pregnant. My first response was, ‘Is it mine?’” the patient said.

Bored Panda

Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) on Wednesday released interim data from the Phase 2 pivotal portion of the PYNNACLE clinical trial evaluating rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FDA Expands Approval For AstraZeneca's Drug For Pediatric Patients With Rare Type Of Cancer

On Wednesday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Koselugo (selumetinib) granules and capsules for pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN), benign, nerve sheath tumors.

Benzinga

Johnson & Johnson's FDA-Approved Bladder Cancer Drug Offers New Option For Patients Avoiding Surgery

On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson Johnson's (NYSE:JNJ) Inlexzo (gemcitabine intravesical system) as a new treatment approach for certain types of bladder cancer patients who need additional options following unsuccessful BCG therapy and for patients refusing or ineligible for bladder removal surgery (radical cystectomy).

Metal Hammer

Iron Maiden’s Bruce Dickinson says he’d have been “comfortable” if cancer treatment irreparably affected his singing voice

“That’s when the thought formed, ‘What do I actually do with my life?’ Am I just a human noise generator? Or am I actually telling stories?”

Evening Standard

Millions could benefit from faster scan to diagnose prostate cancer – study

The scan only takes 15 to 20 minutes and could save the NHS money, researchers say.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst

Johnson Johnson (NYSE:JNJ) on Tuesday won regulatory approval for its drug delivery product Inlexzo to treat high-risk non-muscle invasive bladder cancer, a milestone Goldman Sachs says could launch “a powerful new product cycle” for the company's TAR-200 program.

Evening Standard

Diagnosis pathway detects cancer and serious illness in one in five patients

The Scan pathway was created for people with non-specific symptoms, such as unexplained weight loss or fatigue.

The Independent UK

EastEnders actor shares cancer update with co-stars in emotional video

Heather Peace has said a goodbye to the wig she wore for EastEnders as she admits it’s “time to move on”.

The Independent UK

‘Significant’ increases in cancer patients raising concerns about the level of care, charity says

Cancer patients are raising concerns about delays and pressures in the system

The Independent UK

Cancer patients with care concerns increasing significantly, charity warns

It comes as Macmillan’s annual report showed it reached 2.4 million people affected by the disease in 2024.

MarketBeat

3 Under-the-Radar Biotechs Under $5 That Could Soar 200%

3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.

The Independent UK

Turbo-charged robotic sperm are the future of infertility treatments, scientists say

The sperm bots could be used to treat infertility-causing conditions, including uterine cancer and endometriosis

1 … 188 189 190 191

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.